Pages that link to "Q46669654"
The following pages link to Neoadjuvant treatment of colorectal cancer with bevacizumab: the perioperative angiogenic balance is sensitive to systemic thrombospondin-1 levels (Q46669654):
Displaying 17 items.
- Molecular profiling in the treatment of colorectal cancer: focus on regorafenib (Q26778296) (← links)
- Myelosuppression of thrombocytes and monocytes is associated with a lack of synergy between chemotherapy and anti-VEGF treatment (Q33395123) (← links)
- Predictive model of thrombospondin-1 and vascular endothelial growth factor in breast tumor tissue (Q33897971) (← links)
- Pharmacodynamic and pharmacogenetic angiogenesis-related markers of first-line FOLFOXIRI plus bevacizumab schedule in metastatic colorectal cancer (Q34806780) (← links)
- Discrimination between circulating endothelial cells and blood cell populations with overlapping phenotype reveals distinct regulation and predictive potential in cancer therapy. (Q35444368) (← links)
- Combining bevacizumab and chemoradiation in rectal cancer. Translational results of the AXEBeam trial. (Q35475535) (← links)
- Neoadjuvant bevacizumab persistently inactivates VEGF at the time of surgery despite preoperative cessation (Q36299062) (← links)
- Total and not bevacizumab-bound vascular endothelial growth factor as potential predictive factors to bevacizumab-based chemotherapy in colorectal cancer (Q37096730) (← links)
- The VEGF rise in blood of bevacizumab patients is not based on tumor escape but a host-blockade of VEGF clearance. (Q37636781) (← links)
- Biomarkers to predict the clinical efficacy of bevacizumab in cancer (Q37815281) (← links)
- Molecular Predictors of Response to Antiangiogenesis Therapies (Q37856125) (← links)
- Plasma thrombospondin 1 as a predictor of postoperative liver dysfunction. (Q41076341) (← links)
- The effect of bevacizumab on colon anastomotic healing in rats (Q42944599) (← links)
- Intracellular bevacizumab reduces phagocytotic uptake in RPE cells (Q43156907) (← links)
- Human expression patterns: qualitative and quantitative analysis of thrombospondin-1 under physiological and pathological conditions (Q50019794) (← links)
- Trends in the multimodality treatment of resectable colorectal liver metastases: an underutilized strategy (Q51786105) (← links)
- IL-8 and thrombospondin-1 as prognostic markers in patients with metastatic colorectal cancer receiving bevacizumab (Q59806381) (← links)